Table 1.
Lymphoma subtype among 132 paediatric and adolescent (<18 years) NHL cases
Precursor lymphoid neoplasms | 4 (3%) |
B lymphoblastic leukaemia/lymphoma | 1 (0.7%) |
T lymphoblastic leukaemia/lymphoma | 1 (0.7%) |
Blastic leukaemia/lymphoma, not otherwise specified | 2 (1.5%) |
Mature B-cell neoplasms | 123 (92.5%) |
Diffuse large B-cell lymphoma (DLBCL) | 10 (7.5%) |
Burkitt lymphoma (BL) | 109 (82%) |
B-cell lymphoma, unclassifiable with features intermediate between DLBCL & BL | 4 (3%) |
Mature T-cell & NK cell neoplasms | 3 (2.2%) |
Peripheral T-cell lymphoma, not otherwise specified | 1 (0.7%) |
Anaplastic large cell lymphoma, ALK positive | 2 (1.5%) |
NHL, not further classifiable due to technical reasons | 2 |
DLBCL, diffuse large B-cell lymphoma ; BL, Burkitt lymphoma